Actionable news
0
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

What to Expect When Pfizer (PFE) Releases Third Quarter Results

NEW YORK (TheStreet) -- Shares of Pfizer (PFE - Get Report) are flat at $34 in afternoon trading on Monday, ahead of the release of the company's third quarter earnings results, due out before the market open tomorrow.

Analysts on average are expecting the drug manufacturer to report third quarter earnings of 51 cents per share, a decline of six cents from the 57 cents per share the company reported a year ago.

Revenue for the period is expected to be $11.6 billion, also short of the $12.4 billion Pfizer reported a year ago.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks with serious upside potential in the next 12-months. Learn more.

Pfizer is a New York City-based biopharmaceutical company who's most popular products include Viagra, EpiPen and Lipitor.

Separately, TheStreet Ratings team rates PFIZER INC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:

We rate...


More